Issues

Addressing the COVID-19 pandemic with care and compassion

As the nation continues to confront the coronavirus outbreak, Blue Cross and Blue Shield (BCBS) companies are supporting patients, health care partners and communities with more than $5.5 billion committed to the fight.

BCBS companies have enhanced access to coronavirus care by eliminating key costs and are ensuring that health care systems and physician practices have the financial and medical resources they need to treat patients now and after this pandemic.

Congress made $175 BILLION in relief funds available to the Department of Health and Human Services to send direct assistance to HOSPITALS and HEALTH CARE PRACTITIONERS.  

Source: U.S. Department of Health and Human Services, "CARES Act Provider Relief Fund: General Information."

Older adults, people with an underlying medical condition or those who are immunocompromised may be at a HIGHER RISK OF SERIOUS ILLNESS due to COVID-19.

Source: Centers for Disease Control and Prevention

Currently, there are more than 165 VACCINES being developed worldwide. Of those, 31 are being tested in humans, and 2 have been approved for early or limited use. 

Source: New York Times, “Coronavirus Vaccine Tracker,” August 12, 2020.

The Latest

Learn how BCBS companies are supporting their states and local communities

Read More

WE SUPPORT A NUMBER OF ACTIONS TO HELP INDIVIDUALS AND FAMILIES SAFEGUARD THEIR HEALTH DURING THIS TIME.

2020 Icon COVID Issue DoctorBag

HELPING PEOPLE MAINTAIN, ACCESS AND AFFORD COVERAGE

Provide employer subsidies to preserve health coverage, cover the cost of COBRA coverage and allow for a special enrollment period in the federally facilitated marketplaces for individual coverage.

2020 Icon COVID Issue DollarSign

ENDING SURPRISE BILLS

End balance billing and surprise bills once and for all as part of the next legislative package on COVID-19.

2020 Icon COVID Issue Umbrella

PREPARING TO REOPEN SAFELY

Ensure federal resources and public health support for widespread testing and surveillance to protect all Americans.

Learn more about what we recommend in the next phase of congressional COVID legislation.

Get Email Updates